Skip to content

Clinical trials

Phase 1/2 Thrombocythemia, Essential trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Phase 1/2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20052
20083
20101
20111
20141
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Cancer Treatment Centers of America1
Constellation Pharmaceuticals1
M.D. Anderson Cancer Center1
Mayo Clinic1
NS Pharma, Inc.1
OHSU Knight Cancer Institute1
Ohio State University Comprehensive Cancer Center1
Ronald Hoffman1
S*BIO1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential16
Myeloproliferative Disorders14
Polycythemia Vera14
Primary Myelofibrosis14
Leukemia, Myeloid, Acute9
Myelodysplastic Syndromes8
Leukemia7
Leukemia, Myelomonocytic, Chronic6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia, Neutrophilic, Chronic5

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.